MAP2K7 and hepatocellular carcinoma: Interestingly, this study also indicates that miR-199a/b-3p, the 11th most downregulated miRNA in our results, is a potential therapeutic agent because it can target tumor-promoting PAK4 to suppress HCC growth by inhibiting the PAK4/Raf/MEK/ERK pathway.